Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Breast Cancer Metastatic × irinotecan sucrosofate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 13 Colorectal Neoplasms 5 Small Cell Lung Carcinoma 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Biliary Tract Neoplasms 3 Recurrence 2 Nasopharyngeal Carcinoma 2 Cholangiocarcinoma 2 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Non-resectable 1 Pancreatic Cancer Metastatic to Liver 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Neoadjuvant Chemotherapy 1 Metastatic Pancreatic Adenocarcinoma 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Gallbladder Neoplasms 1 Efficacy and Safety 1 Colorectal Cancer Metastatic 1

Interventions

Fulvestrant 5 Letrozole 3 ribociclib 2 exemestane 2 dalpiciclib 2 apatinib 2 Gemcitabine 2 Capecitabine 2 Anastrozole 2 tusamitamab ravtansine 1 trastuzumab deruxtecan 1 palbociclib 1 margetuximab 1 irinotecan sucrosofate 1 fluzoparib 1 abemaciclib 1 Vinorelbine 1 Trastuzumab 1 Tamoxifen 1 Paclitaxel 1 Liposomes 1 Irinotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03328884 2025-04-23

Phenomenal

MedSIR

Phase 2 Completed

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡